Tirzepatide, a recently approved medication, is generating considerable interest within the scientific community. It functions differently from traditional diabetes therapies , targeting multiple receptors involved in blood regulation and appetite . Initial research have demonstrated remarkable efficacy in reducing blood glucose in individuals with